Validity of dynamic contrast-enhanced magnetic resonance imaging of the breast versus diffusion-weighted imaging and magnetic resonance spectroscopy in predicting the malignant nature of non-mass enhancement lesions

被引:2
作者
Bayoumi, Dalia [1 ]
Shokeir, Farah Ahmed [1 ]
Karam, Rasha [1 ]
Elboghdady, Aya [1 ]
机构
[1] Mansoura Univ, Fac Med, Dept Radiol, Mansoura, Egypt
关键词
Breast cancer; MRI breast; Time-intensity curve; Non-mass enhancement lesions; DWI; MRS; Multiparametric-MRI; MRI; DIAGNOSIS; CANCER;
D O I
10.1186/s43055-024-01267-2
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Background Breast cancer is the commonest cancer affecting women worldwide. So, it is important to accurately detect and classify different breast lesions. Noninvasive methods for tissue characterization have increased interest, particularly for early diagnosis. Non-mass enhancement (NME) breast lesions are described in magnetic resonance imaging (MRI) as the presence of enhancement without space-occupying lesions. Several studies have described that certain characteristics can be used as new indicators of malignancy in breast NME lesions. We aimed to study the role of multiparametric-MRI (Mp-MRI) as diffusion-weighted imaging (DWI) and magnetic resonance spectroscopy (MRS) in assessment of NME lesions and to suggest which one offers the greatest diagnostic accuracy. Methods This retrospective study was conducted from March 2017 to December 2023 on 220 NME breast lesions. All lesions were analyzed to study the features of benign and malignant NME lesions using different MRI techniques including dynamic contrast-enhanced MRI (DCE-MRI), DWI, and MRS. Breast MRI was performed at 1.5 Tesla, findings were correlated with histopathological results of all cases. Results Patients' mean age was 46.56 years with 220 NME breast lesions (54 were benign and 166 were malignant). Invasive ductal carcinoma with ductal carcinoma in situ was the most malignant type representing 93 cases. We found that segmental distribution, heterogeneous enhancement, type III curve, restricted diffusion, lower apparent diffusion coefficient, and positive choline peak were more with malignancy (P = 0.008, 0.02, 0.004, 0.001, and < 0.001). We detected that Mp-MRI has higher diagnostic accuracy than DCE-MRI and combined other functional sequences (DWI, MRS), it was 91.2% with sensitivity 89.9%, specificity 87.8%, positive predictive value 89.2%, and negative predictive value 82.2%. Conclusions Functional MRI techniques, such as DWI and MRS, can provide helpful information in assessment of NME lesions. They have high diagnostic accuracy, sensitivity, and specificity in characterizing NME breast lesions as benign or malignant. However, DCE-MRI is mandatory for lesion characterization and delineation of its nature and cannot be replaced by them alone in cases of lesion visualization. So, multiparametric-MRI can improve the diagnostic accuracy of NME breast lesions when combined with dynamic contrast-enhanced MRI and can help in reducing negative biopsy rates.
引用
收藏
页数:15
相关论文
共 33 条
[1]   Grading system to categorize breast MRI using BI-RADS 5th edition: a statistical study of non-mass enhancement descriptors in terms of probability of malignancy [J].
Asada, Tatsunori ;
Yamada, Takayuki ;
Kanemaki, Yoshihide ;
Fujiwara, Keishi ;
Okamoto, Satoko ;
Nakajima, Yasuo .
JAPANESE JOURNAL OF RADIOLOGY, 2018, 36 (03) :200-208
[2]   Limited role of DWI with apparent diffusion coefficient mapping in breast lesions presenting as non-mass enhancement on dynamic contrast-enhanced MRI [J].
Avendano, Daly ;
Marino, Maria Adele ;
Leithner, Doris ;
Thakur, Sunitha ;
Bernard-Davila, Blanca ;
Martinez, Danny F. ;
Helbich, Thomas H. ;
Morris, Elizabeth A. ;
Jochelson, Maxine S. ;
Baltzer, Pascal A. T. ;
Clauser, Paola ;
Kapetas, Panagiotis ;
Pinker, Katja .
BREAST CANCER RESEARCH, 2019, 21 (01)
[3]   Differentiating benign and malignant mass and non-mass lesions in breast DCE-MRI using normalized frequency-based features [J].
Ayatollahi, Fazael ;
Shokouhi, Shahriar B. ;
Teuwen, Jonas .
INTERNATIONAL JOURNAL OF COMPUTER ASSISTED RADIOLOGY AND SURGERY, 2020, 15 (02) :297-307
[4]   The MRI characteristics of non-mass enhancement lesions of the breast: associations with malignancy [J].
Aydin, Hale .
BRITISH JOURNAL OF RADIOLOGY, 2019, 92 (1096)
[5]   Enhancing nonmass lesions in the breast:: Evaluation with proton (1H) MR spectroscopy [J].
Bartella, Lia ;
Thakur, Sunitha B. ;
Morris, Elizabeth A. ;
Dershaw, D. David ;
Huang, Wei ;
Chough, Eugenia ;
Cruz, Maria C. ;
Liberman, Laura .
RADIOLOGY, 2007, 245 (01) :80-87
[6]   Current State of Breast Cancer Diagnosis, Treatment, and Theranostics [J].
Bhushan, Arya ;
Gonsalves, Andrea ;
Menon, Jyothi U. .
PHARMACEUTICS, 2021, 13 (05)
[7]   Significance of Additional Non-Mass Enhancement in Patients with Breast Cancer on Preoperative 3T Dynamic Contrast Enhanced MRI of the Breast [J].
Cho, Yun Hee ;
Cho, Kyu Ran ;
Park, Eun Kyung ;
Seo, Bo Kyoung ;
Woo, Ok Hee ;
Cho, Sung Bum ;
Bae, Jeoung Won .
IRANIAN JOURNAL OF RADIOLOGY, 2016, 13 (01) :1-7
[8]   Multi-parametric dynamic contrast enhanced MRI, diffusion-weighted MRI and proton-MRS in differentiation of benign and malignant breast lesions: Imaging interpretation and radiology-pathology correlation [J].
Ebrahim, Youstina G. S. ;
Louis, Mariam R. ;
Ali, Engy A. .
EGYPTIAN JOURNAL OF RADIOLOGY AND NUCLEAR MEDICINE, 2018, 49 (04) :1175-1181
[9]   Proton MR spectroscopy in the breast: Technical innovations and clinical applications [J].
Fardanesh, Reza ;
Marino, Maria Adele ;
Avendano, Daly ;
Leithner, Doris ;
Pinker, Katja ;
Thakur, Sunitha B. .
JOURNAL OF MAGNETIC RESONANCE IMAGING, 2019, 50 (04) :1033-1046
[10]  
Gilbert FJ, 2019, IDKD SPR SER, P155, DOI 10.1007/978-3-030-11149-6_13